EP300 and Hepatic fibrosis: Abrogation of EP300 activity was as efficient to attenuate fibrosis in vitro and in vivo as the cholangiocyte-selective EP300 KO, in a ACTA2-AS1 dependent manner, which indicates the reversible cooperation between EP300 and lncRNAs during liver fibrosis [107].